Navigation Links
Waters Introduces New TruView LCMS Certified Vials for the Analytical Laboratory
Date:9/29/2011

MILFORD, Mass., Sept. 29, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today introduced TruView™ LCMS Certified Vials, a new line of low-adsorption sample vials certified for LC/MS/MS analyses where analyte concentrations are on the order of ng/mL or pg/mL and where analytical sensitivity and accuracy are critical.

(Logo: http://photos.prnewswire.com/prnh/20110707/NE31586LOGO)

"As LC/MS/MS technology evolves and levels of detection approach or exceed the part-per-trillion range, our customers are demanding low adsorption vials that won't compromise their results," said Mike Yelle, Senior Director, Chemistry Commercial Operations, Waters Division. "Our TruView glass vials are manufactured and certified to perform better than any commercially available glass autosampler vial."

TruView vials are manufactured under tight controls using a proprietary process that limits the concentration of free ions on the surface of the glass dramatically lowering analyte adsorption.  Normally during the manufacture of glass vials, free ions are deposited on the surface. Problems occur when the ions are freed from the surface and enter the sample raising the pH and exposing ion exchange sites on the glass to sample analytes that can bind to the glass. The longer a vial awaits aspiration and injection of its contents, the greater the analyte adsorption.

Waters TruView LCMS Certified Vials are now available from Waters worldwide.

More information: www.waters.com/vials

About Waters Corporation (www.waters.com)

For more than 50 years, Waters Corporation (NYSE: WAT) has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.64 billion in 2010 and 5,400 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters and TruView are trademarks of Waters Corporation.


'/>"/>
SOURCE Waters Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Waters Showcases ACQUITY UltraPerformance LC and Mass Spectrometry (UPLC/MS) Tools for Increasing Laboratory Efficiency at the American Association for Clinical Chemistry Annual Meeting
2. Waters CE Marks In Vitro Diagnostic MassTrak Immunosuppressants XE Kit
3. Waters Introduces Ostro Sample Preparation Products
4. Waters Expands Xevo MS Instrument Platform With Next-Generation Mass Spectrometers
5. Waters Corporation and NIBRT Partner to Bring Greater Control and Predictability to Biopharmaceutical Processing
6. Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard
7. New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals
8. BD Biosciences Introduces New Device Designed to Increase Cell Growth and Cell Culture Productivity
9. Ethicon Endo-Surgery Introduces First Powered Endocutter with Enhanced System-Wide Compression and Stability, Allowing Surgeons Greater Control in Laparoscopic Surgery
10. Cardinal Health Introduces New Latex, Powder-Free, Hydrogel Surgical Gloves
11. Sensitech Inc. Introduces Temperature and Humidity Monitor for Flammable and Hazardous Environments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... June 30, 2017, and updated its financial outlook for ... For the fiscal third quarter, Hill-Rom reported earnings of ... share in the prior-year period. These results reflect after-tax ... share primarily related to the non-cash write-down of assets ...
(Date:7/27/2017)... Pa., July 27, 2017  West Pharmaceutical Services, Inc. ... results for the second-quarter 2017 and updated financial guidance ... Second-Quarter 2017 Highlights Reported net ... over the prior-year quarter. Net sales at constant currency ... reported-diluted EPS was $0.51, compared to $0.60 in the ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology:
(Date:8/16/2017)... Lewisville, TX (PRWEB) , ... August 16, 2017 , ... ... in the United States, named Dr. Douglas J. Harrison, as the new Medical Director ... will be the new facility Medical Director of our Sienna Plantation location,” said Dr. ...
(Date:8/16/2017)... ... , ... “God Will Break Every Chain”: an inspirational story for those shackled by the chains ... author, Evangelist Joann Shivers, a writer and a woman of great faith and wisdom. ... early age. She was born and raised in Vero Beach, Florida and has dedicated ...
(Date:8/15/2017)... ... August 15, 2017 , ... The first study to ... multiple myeloma has been completed, with the team’s findings now published online ahead of ... , Director of the Blood and Marrow Transplant Program at Roswell Park Cancer Institute, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Progressive Dental, a leading ... on the 2017 Fast 50 list of Fastest Growing Companies in Tampa Bay. The ... area who has shown three consecutive years of growth. For this year’s award, Progressive ...
(Date:8/15/2017)... ... August 15, 2017 , ... Dr. Timothy Davis ... periodontal disease . This information can be used to develop patient-specific treatment ... The two salivary diagnostic tests, named MyPerioPath® and MyPerioID® are offered by OralDNA® ...
Breaking Medicine News(10 mins):